PET helps differentiate between Alzheimer's, HIV complication

01/19/2012 | Medscape (free registration)

A study published in the Archives of Neurology said PET imaging with carbon 11–labeled Pittsburgh compound B helps distinguish HIV-associated neurocognitive disorder from Alzheimer's disease. In the study, patients with symptomatic Alzheimer's had higher C-PiB uptake. Researchers said there is a need for additional studies to better understand the use of the imaging method in older patients with the HIV-related disorder.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD